<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-IJTDMVR9/3d5533a1-a30d-4212-80a1-cba0255f7009/PDF"><dcterms:extent>784 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-IJTDMVR9/cea123fb-c632-4a2c-95cf-d4224dc7c4e3/TEXT"><dcterms:extent>26 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-IJTDMVR9"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>2017</dcterms:issued><dc:creator>Čavka, Luka</dc:creator><dc:creator>Čufer, Tanja</dc:creator><dc:creator>Janžič, Andrej</dc:creator><dc:creator>Janžič, Urška</dc:creator><dc:creator>Kern, Izidor</dc:creator><dc:format xml:lang="sl">letnik:51</dc:format><dc:format xml:lang="sl">številka:iss. 3</dc:format><dc:format xml:lang="sl">str. 357-362</dc:format><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>COBISSID_HOST:4381553</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-IJTDMVR9</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Association of Radiology and Oncology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="en">adenocarcinoma</dc:subject><dc:subject xml:lang="sl">Adenokarcinom</dc:subject><dc:subject xml:lang="en">immune cells</dc:subject><dc:subject xml:lang="sl">Imunoterapija</dc:subject><dc:subject xml:lang="sl">lung cancer</dc:subject><dc:subject xml:lang="sl">Onkologija</dc:subject><dc:subject xml:lang="en">PD-L1 expression</dc:subject><dc:subject xml:lang="en">squamous-cell lung cancer</dc:subject><dc:subject xml:lang="en">tumor cells</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">PD-L1 expression in squamous-cell carcinoma and adenocarcinoma of the lung|</dc:title><dc:description xml:lang="sl">With introduction of immunotherapy (IT) into the treatment of advanced non-small-cell lung cancer (NSCLC), a need for predictive biomarker became apparent. Programmed death ligand 1 (PD-L1) protein expression is most widely explored predictive marker for response to IT. We assessed PD-L1 expression in tumor cells (TC) and immune cells (IC) of squamous-cell carcinoma (SCC) and adenocarcinoma (AC) patients. We obtained 54 surgically resected tumor specimens and assessed PD-L1 expression by immunohistochemistry after staining them with antibody SP142 (Ventana, USA). Clinicopathological characteristics were acquired from the hospital registry database. Results were analyzed according to cut-off values of % 5% and % 10% of PD-L1 expression on either TC or IC. 29 (54%) samples were AC and 25 (46%) were SCC. PD-L1 expression was significantly higher in TC of SCC compared to AC at both cut-off values (52% vs. 17%, p = 0.016 and 52% vs. 14%, p = 0.007, respectively) no difference in PD-L1 expression in IC of SCC and AC was found. In AC alone, PD-L1 expression was significantly higher in IC compared to TC at both cut-off values (72% vs. 17%, p &lt; 0.001 and 41% vs. 14%, p = 0.008, respectively), while no significant difference between IC and TC PD-L1 expression was revealed in SCC. Our results suggest a significantly higher PD-L1 expression in TC of SCC compared to AC, regardless of the cut-off value. PD-L1 expression in IC is high in both histological subtypes of NSCLC, and adds significantly to the overall positivity of AC but not SCC</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-IJTDMVR9"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-IJTDMVR9" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-IJTDMVR9/3d5533a1-a30d-4212-80a1-cba0255f7009/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo radiologije in onkologije</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-IJTDMVR9/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-IJTDMVR9" /></ore:Aggregation></rdf:RDF>